| Name | Title | Contact Details |
|---|---|---|
Steve Collins |
Chief Information Officer | Profile |
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
National Clinical Research is a Richmond, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Coventry Health Care, Inc. (Coventry) is a diversified national insurer in the United States. Based in Bethesda, Maryland, Coventry operates health plans, insurance companies, network rental and workers’ compensation services companies. Coventry provides a full range of risk and fee-based managed care products and services to a broad cross section of individuals, employer and government-funded groups, government agencies, and other insurance carriers and administrators. It is currently ranked the third most successful prescription drug plan service in the United States.
Dietz Hwkins Internal Medicine is a Sandy, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medical Practice Innovations is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.